INDV
Indivior Pharmaceuticals, Inc.
Stock
$35.71+0.33 (+0.93%)Close Oct 2, 2026
- Revenue, 2025
- $1.2B
- YoY, 2025
- +4.3%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $1.2B | +4.3% |
| 2024 | $1.2B | +8.7% |
| 2023 | $1.1B | +21.3% |
| 2022 | $901M | +13.9% |
| 2021 | $791M | — |
Indivior Pharmaceuticals, Inc.
$35.71+0.33 (+0.93%)Close Oct 2, 2026
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $1.2B | +4.3% |
| 2024 | $1.2B | +8.7% |
| 2023 | $1.1B | +21.3% |
| 2022 | $901M | +13.9% |
| 2021 | $791M | — |